WHO approves Bavarian Nordic’s mpox vaccine for adolescents
The World Health Organization says on Monday that it had approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disease that…